This early-stage study is testing the safety of a personalized vaccine designed to teach the immune system to attack a man's specific prostate cancer. It is for men with aggressive prostate cancer who have had their prostate removed but still have a high risk of the cancer coming…
Phase: PHASE1 • Sponsor: Ashutosh Kumar Tewari • Aim: Disease control
Last updated Feb 25, 2026 15:05 UTC